Rivanna Medical
  • Products
    • ProductsAccuro
    • Consumables
    • Trolley
  • Resources
    • TrainingTraining
    • Testimonials
    • Clinical Value
    • Articles & Press
    • Upgrade
  • About
    • AboutRIVANNA
    • Leadership & BOD
    • Careers
  • Contact
    • ContactContact Us
    • Return Policy
  • Get Quote
Select Page

BARDA awards nearly $10 million to RIVANNA to accelerate development of CADe/x AI module for Accuro XV

by RIVANNA | Jul 28, 2025 | Press Releases

CHARLOTTESVILLE, VA – JULY 28, 2025 – RIVANNA®, developer of imaging-based medical technologies, announced that it received $9.92 million in federal funding of a contractual option from the Biomedical Advanced Research and Development Authority (BARDA), part of the...

RIVANNA’s next-generation ultrasound guidance platform and AI-driven imaging software receive FDA 510(K) clearance

by RIVANNA | Jul 15, 2025 | Press Releases

CHARLOTTESVILLE, VA – JULY 15, 2025 – RIVANNA®, developer of world-first imaging-based medical technologies, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) regarding the Accuro® 3S diagnostic ultrasound system and...
Building a Health System to Support Aging Populations [6 Steps]

Building a Health System to Support Aging Populations [6 Steps]

by RIVANNA | Jun 29, 2025 | News

There is a significant shift occurring in the demographic composition of many developed countries: the aging of their populations. For the healthcare sector in the U.S., this presents a major challenge as a larger number of elderly people will need medical care....
Some Studies Show Up to 25% Fewer Assisted Deliveries With Low-Dose Epidurals

Some Studies Show Up to 25% Fewer Assisted Deliveries With Low-Dose Epidurals

by RIVANNA | Jun 10, 2025 | News

The management of labor pain has always walked a fine line between efficacy and impact on mobility. Traditional epidural techniques, while effective in pain relief, often result in significant motor block that limits maternal movement. This issue is increasingly at...

RIVANNA selected for prestigious MedTech Innovator 2025 Accelerator Cohort

by RIVANNA | Jun 9, 2025 | Press Releases

— One of 65 startups chosen from nearly 1,500 global applicants — — Selected to participate in the world’s leading medtech accelerator — Charlottesville, VA, USA — June 9, 2025 — RIVANNA®, a medical device innovator and manufacturer focused on imaging-based medical...
« Older Entries
Next Entries »

Recent Posts

  • Solving the Blind Procedure Problem in Modern Obstetric Anesthesia
  • RIVANNA’s 2025 Year in Review: Medical Imaging Innovation Across U.S. Healthcare
  • Global Neuraxial Practices: How Regional Differences Shape Patient Outcomes
  • RIVANNA announces FDA clearance of Accuro 3S Needle Guide Kit
  • Advancing Obstetric Anesthesia: Dr. Steven Garber on the Real-World Power of Accuro 3S

Boost your first attempt success by 81% with Accuro.


Careers

Our imaging-based medical technology not only elevates global standards of care but also unlocks a world of opportunity for those at the forefront. The mission is monumental. Our strategy? Teamwork. That’s why we invest in our people, foster shared values, and prioritize developmental opportunities. We believe in enabling discovery, fostering innovation, and nurturing leadership. It’s all about promoting outstanding personal achievement and well-being. View our current job openings.

Connect


  • Facebook

  • X
  • yt
  • ln

  • Instagram
PRODUCTS SOLUTIONS RESOURCES ABOUT CONTACT
Accuro Industry Training RIVANNA Contact Sales
Consumables Investors Testimonials Leadership & BOD Return Policy
Trolley Clinical Value Careers
Articles & Press
Upgrade
PRODUCTS SOLUTIONS
Accuro Industry
Consumables Investors
Trolley
RESOURCES ABOUT
Training RIVANNA
Testimonials Leadership & BOD
Clinical Value Careers
Articles & Press
Upgrade
CONTACT
Contact Sales
Return Policy

© 2025 Rivanna Medical, Inc. | 2400 HUNTERS WAY | CHARLOTTESVILLE, VA 22911 | Privacy Policy | Terms and Conditions | Designed by ProvenContent.com